S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
66,000% upside on tiny biotech? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
The perfect AI stock under $10 (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
66,000% upside on tiny biotech? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
The perfect AI stock under $10 (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
66,000% upside on tiny biotech? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
The perfect AI stock under $10 (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
A collection of the insights Warren Buffett offered in his annual letter Saturday
66,000% upside on tiny biotech? (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Consumers are increasingly pushing back against price increases — and winning
The perfect AI stock under $10 (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
The perfect AI stock under $10 (Ad)
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Federal prosecutors accuse a New Mexico woman of fraud in oil and gas royalty case

Avenue Therapeutics (ATXI) Institutional Ownership

$0.13
-0.01 (-6.92%)
(As of 02/23/2024 ET)

Institutional Ownership Changes (13F Filings) for Avenue Therapeutics (NASDAQ:ATXI)

Current
Institutional Ownership
Percentage
9.38%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$101,474.17
Number of
Institutional Sellers
(last 12 months)
0
Get ATXI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ATXI Institutional Buying and Selling by Quarter


Avenue Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/11/2023Geode Capital Management LLC52,571$60K0.0%+359.9%0.665%
5/16/2023Sabby Management LLC279,898$0.33M0.3%+6.0%3.534%
5/16/2023State Street Corp30,593$36K0.0%N/A0.386%
2/15/2023Virtu Financial LLC32,570$38K0.0%N/A0.641%
11/15/2022Two Sigma Investments LP14,342$0.15M0.0%N/A0.972%
11/15/2022Citadel Advisors LLC35,865$0.36M0.0%N/A2.423%
8/13/2022Renaissance Technologies LLC124,400$34K0.0%N/A0.572%
5/17/2022Virtu Financial LLC58,004$28K0.0%N/A0.267%
1/28/2022National Asset Management Inc.71,338$65K0.0%-20.1%0.376%
11/16/2021National Asset Management Inc.89,237$0.13M0.0%-29.2%0.531%
10/19/2021Kestra Advisory Services LLC22,500$34K0.0%N/A0.134%
9/17/2021Virtu Financial LLC26,373$66K0.0%N/A0.157%
9/3/2021Parametric Portfolio Associates LLC10,554$26K0.0%-59.2%0.063%
8/16/2021Occudo Quantitative Strategies LP14,398$36K0.0%N/A0.086%
8/13/2021Renaissance Technologies LLC78,314$0.20M0.0%N/A0.468%
8/13/2021Northern Trust Corp13,767$35K0.0%-82.1%0.082%
8/13/2021Geode Capital Management LLC79,556$0.20M0.0%-40.0%0.475%
8/13/2021Vanguard Group Inc.449,982$1.13M0.0%-35.5%2.687%
8/12/2021XTX Topco Ltd10,864$27K0.0%N/A0.065%
8/12/2021Advisory Services Network LLC35,121$88K0.0%N/A0.210%
8/12/2021Ergoteles LLC30,400$76K0.0%N/A0.182%
8/10/2021National Asset Management Inc.126,037$0.32M0.0%-26.1%0.753%
5/20/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060%
5/19/2021Squarepoint Ops LLC11,668$71K0.0%N/A0.070%
5/17/2021Goldman Sachs Group Inc.17,319$0.11M0.0%N/A0.103%
5/13/2021Trexquant Investment LP13,874$84K0.0%N/A0.083%
5/13/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060%
5/13/2021Barclays PLC5,568$34K0.0%+159.0%0.033%
5/12/2021Northern Trust Corp77,049$0.47M0.0%-6.8%0.460%
5/12/2021Geode Capital Management LLC132,594$0.80M0.0%+5.9%0.792%
2/24/2021Virtu Financial LLC17,469$0.10M0.0%N/A0.104%
2/19/2021JPMorgan Chase & Co.17,102$0.10M0.0%+260.2%0.102%
2/17/2021Jane Street Group LLC13,288$79K0.0%N/A0.079%
2/11/2021Northern Trust Corp82,691$0.49M0.0%+2.1%0.494%
2/9/2021Wells Fargo & Company MN16,406$98K0.0%-13.2%0.098%
2/5/2021BlackRock Inc.361,486$2.15M0.0%+5.5%2.158%
2/4/2021National Asset Management Inc.167,787$1M0.1%+15.0%1.002%
11/13/2020Morgan Stanley22,706$0.25M0.0%+270.9%0.136%
11/10/2020State Street Corp73,316$0.79M0.0%+9.5%0.438%
11/9/2020National Asset Management Inc.145,887$1.58M0.1%+42.7%0.871%
11/6/2020BlackRock Inc.342,742$3.71M0.0%+7.4%2.052%
10/20/2020Nisa Investment Advisors LLC19,069$0.21M0.0%N/A0.114%
8/25/2020Nuveen Asset Management LLC32,114$0.35M0.0%N/A0.192%
8/20/2020Charles Schwab Investment Management Inc.14,314$0.16M0.0%N/A0.086%
8/17/2020Jane Street Group LLC14,010$0.15M0.0%N/A0.084%
8/14/2020Bank of America Corp DE2,694$29K0.0%-62.0%0.016%
8/12/2020American International Group Inc.4,075$44K0.0%N/A0.024%
8/12/2020Bank of New York Mellon Corp15,032$0.16M0.0%N/A0.090%
8/7/2020New York State Common Retirement Fund9,000$97K0.0%N/A0.054%
7/31/2020National Asset Management Inc.102,200$1.10M0.1%+6.5%0.613%
7/31/2020UBS Group AG6,328$68K0.0%+216.4%0.038%
7/31/2020Mackay Shields LLC25,300$0.27M0.0%N/A0.152%
5/18/2020Advisor Group Holdings Inc.33,745$0.30M0.0%N/A0.202%
5/15/2020Squarepoint Ops LLC19,410$0.17M0.0%N/A0.116%
5/15/2020Morgan Stanley4,691$42K0.0%+47.3%0.028%
5/14/2020Geode Capital Management LLC70,115$0.63M0.0%+3.2%0.420%
5/9/2020National Asset Management Inc.96,000$0.86M0.1%+25.9%0.576%
5/1/2020BlackRock Inc.47,057$0.42M0.0%+7.9%0.282%
2/13/2020Renaissance Technologies LLC12,553$0.12M0.0%N/A0.075%
2/10/2020National Asset Management Inc.76,250$0.73M0.1%+3.4%0.458%
11/27/2019Squarepoint Ops LLC12,726$76K0.0%N/A0.076%
(Data available from 1/1/2016 forward)













ATXI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ATXI shares?

During the previous two years, the following institutional investors and hedge funds held shares of Avenue Therapeutics shares: Citadel Advisors LLC ($0.36M), Sabby Management LLC ($0.33M), Two Sigma Investments LP ($0.15M), Geode Capital Management LLC ($60K), Virtu Financial LLC ($38K), and State Street Corp ($36K), and Renaissance Technologies LLC ($34K).Learn more on ATXI's institutional investors.

What percentage of Avenue Therapeutics stock is owned by institutional investors?

9.38% of Avenue Therapeutics stock is owned by institutional investors. Learn more on ATXI's institutional investor holdings.

Which institutional investors have been buying Avenue Therapeutics stock?

The following institutional investors have purchased Avenue Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($0.12M), Virtu Financial LLC ($90.57K), Geode Capital Management LLC ($41.14K), Citadel Advisors LLC ($35.87K), State Street Corp ($30.59K), Sabby Management LLC ($15.90K), and Two Sigma Investments LP ($14.34K).

How much institutional buying is happening at Avenue Therapeutics?

Institutional investors have bought a total of 352,813 shares in the last 24 months. This purchase volume represents approximately $1.57M in transactions.


This page (NASDAQ:ATXI) was last updated on 2/25/2024 by MarketBeat.com Staff